Document Detail


Adenosine-enhanced ischemic preconditioning decreases infarct in the regional ischemic sheep heart.
MedLine Citation:
PMID:  9725373     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Recently we have reported a myoprotective protocol, adenosine-enhanced ischemic preconditioning, that extends the protection afforded by ischemic preconditioning in the isolated crystalloid-perfused heart. In this report the efficacy of adenosine-enhanced ischemic preconditioning in the in situ blood-perfused heart was investigated.
METHODS: Sheep were subjected to 60 minutes of regional ischemia and 120 minutes of reperfusion. Ischemic preconditioned hearts received 5 minutes of zero flow regional ischemia and 5 minutes of reperfusion before regional ischemia. Adenosine-enhanced ischemic preconditioned hearts received a bolus injection of 10 mmol adenosine at the immediate start of ischemic preconditioning. Adenosine-treated hearts received an adenosine bolus, 10 minutes before regional ischemia. The ratio of infarct size to area at risk and mechanical function were determined.
RESULTS: The infarct size to area at risk ratio in regional ischemia was 55.4%+/-2.1%. This ratio was significantly decreased with ischemic preconditioning and adenosine (22.2%+/-2.2% and 19.3%+/-1.4%, respectively; p < 0.001 versus regional ischemia) and adenosine-enhanced ischemic preconditioning (8.0%+/-2.0%, p < 0.001 versus regional ischemia and ischemic preconditioning, and p < 0.01 versus adenosine).
CONCLUSIONS: Adenosine-enhanced ischemic preconditioning significantly decreases infarct size in the in situ blood-perfused heart and provides superior protection compared with ischemic preconditioning.
Authors:
M Uematsu; G R Gaudette; J O Laurikka; S Levitsky; J D McCully
Related Documents :
8781823 - Effects of a1 adenosine receptor blockade by bamiphylline on ischaemic preconditioning ...
8239983 - Cardiac preconditioning. induction of endogenous tolerance to ischemia-reperfusion injury.
16777513 - A quantitative evaluation of st-segment changes on the 18-lead electrocardiogram during...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  66     ISSN:  0003-4975     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  1998 Aug 
Date Detail:
Created Date:  1998-09-11     Completed Date:  1998-09-11     Revised Date:  2013-04-30    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  382-7     Citation Subset:  AIM; IM    
Affiliation:
Division of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02115, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenosine / pharmacology*
Animals
Blood Pressure
Heart Rate
Ischemic Preconditioning, Myocardial / methods*
Myocardial Infarction / prevention & control*
Myocardial Ischemia / prevention & control
Myocardium / pathology
Sheep
Grant Support
ID/Acronym/Agency:
HL 29077/HL/NHLBI NIH HHS; R01 HL029077/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
58-61-7/Adenosine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Integrilin prevents prolonged bleeding times after cardiopulmonary bypass.
Next Document:  Surgical management of ascending and aortic arch disease: refined techniques with improved results.